Antihyperglycemic nor-chamigrane sesquiterpenoids from the fungus Antrodiella albocinnanmomea
Hui Liu1, Jiaoxian Du2, Hongfei Li3
1Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, 430060, PR China; School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan, 430074, PR China.
Abstract:
Eight previously undescribed nor-chamigrane sesquiterpenoids, designated as antrodiellones A‒H (1‒8), were isolated from fermentation broth of Antrodiella albocinnamomea. Notably, antrodiellone A (1) features a unique carbon skeleton. Their structures were elucidated by comprehensive spectroscopic analyses, quantum calculations, and X-ray crystallography. Antihyperglycemic evaluation revealed that all compounds, as well as the positive control metformin, dose-dependently enhanced glucose consumption in insulin-resistant (IR) HepG2 cells. Specifically, compounds 1 and 3 upregulated the mRNA expression of serine/threonine kinase (AKT) and glucose transporter type 4 (GLUT4) genes, while downregulating phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase). Furthermore, these compounds significantly increased GLUT4 protein expression. These findings suggest that these nor-sesquiterpenoids may hold therapeutic potential for managing metabolic disorders associated with insulin resistance.
Related Concept Videos
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Antifungal Agents
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Oral Hypoglycemic Agents: Glinides
Anthelminthic Agents
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

